Patent 11920169 was granted and assigned to Sangamo Therapeutics on March, 2024 by the United States Patent and Trademark Office.
Disclosed herein are compositions for linking DNA binding domains and cleavage domains (or cleavage half-domains) to form non-naturally occurring nucleases with alternative configurations. Also described are methods of making and using compositions comprising these linkers.